*Refresh the page if the below document does not appear.
Merck Pharma commonly known as MSD in India has decided to sell its blockbuster antidiabetic drugs Januvia and Janumet. Analysts speculate top companies might be interested in the deal and the valuation might be around INR2,000 crore.
The NPPA (National Pharmaceutical Pricing Authority) has released the draft working sheets for the fixation of the ceiling prices of around 954 formulations consisting of 388 medicines, based on the database from Pharmatrac published in July’22 .
The biosimilars manufacturing facility of Biocon Ltd. announced the acquisition of the global biosimilars business of its partner Viatris for $3 billion. They have already paid an upfront cash of $2 billion and have issued Compulsorily Convertible Preference Shares (CCPS) of $1 billion.
Drug major Zydus Lifesciences Ltd. has decided to enter into a Business Transfer Agreement (“BTA”) to buy one of the business undertakings of Watson Pharma Private Limited which is involved in the research, manufacturing, marketing, and sale of APIs.
According to investors, Gland pharma’s first overseas acquisition is margin dilutive and therefore might put a weight on the earnings of the company. Thus, the firm saw a 5.4 percent decline in the trading of its stock after the acquisition.
On Wednesday, JB Pharma announced that their company has received USFDA approval for their ANDA (Abbreviated New Drug Application) for Venlafaxine Extended-Release Tablets 37.5 mg, 75 mg, 150 mg, and 225 mg.
In a CEO Roundtable at the 15th CPHI & PMEC India held on Tuesday, the CEOs of pharma firms expressed the need to have a separate ministry for pharmaceuticals to encourage domestic manufacturers and reduce the dependence on Chinese imports.
If you don’t already have an account click the button below to create your account.Create New Account
Please update your profile to keep using the website